Stage IV cancer, often written as “stage 4,” means cancer that has spread from where it originally started to a distant part of the body. This spread to faraway organs is called metastasis, and it’s the defining feature that separates stage IV from earlier stages. A stage IV diagnosis doesn’t describe a single disease. It applies to nearly any cancer type once distant spread has been confirmed.
One important detail that often surprises people: metastatic cancer keeps the name of its original location. Breast cancer that spreads to the lungs is still called breast cancer, not lung cancer. Under a microscope, those cells in the lung still look like breast cells. This distinction matters because treatment targets the original cancer type, not the organ where it landed.
How Cancer Reaches Distant Organs
Cancer cells spread through two main highway systems in your body: the bloodstream and the lymphatic system. In the bloodstream route, tumor cells break away from the original tumor, enter blood vessels, travel as circulating tumor cells, and eventually settle in a distant organ. There, they can grow into new tumors.
The lymphatic route works differently. Cancer cells can enter the network of lymph vessels and nodes that normally help your immune system. Some cancers, like breast cancer, tend to invade lymphatic vessels first. Once cancer cells reach a lymph node, they can gain access to the wider blood circulation and travel to distant sites. Cancer cells can even trigger the growth of new lymphatic vessels around a tumor, essentially building their own escape routes.
Not every cancer cell that enters the bloodstream survives. The vast majority die along the way. But the ones that do survive and establish themselves in a new organ are what make stage IV cancer so challenging to treat, because the disease is no longer confined to one area.
Where Stage IV Cancer Typically Spreads
The most common sites for metastasis are the bones, lungs, liver, and brain. Different cancers have preferred destinations. Breast cancer frequently spreads to bones, lungs, liver, and brain. Lung cancer often metastasizes to the brain, bones, and liver. Colorectal cancer tends to reach the liver and lungs first. Prostate cancer most commonly spreads to bones. These patterns aren’t random. They reflect the blood flow from the original tumor and the chemical signals between cancer cells and specific organs.
Symptoms of Stage IV Cancer
Symptoms depend heavily on where the cancer has spread. Bone metastases often cause deep, persistent pain and can weaken bones enough to cause fractures. Liver metastases may lead to jaundice, abdominal swelling, or nausea. Brain metastases can trigger headaches, seizures, or changes in vision and balance. Lung metastases may cause shortness of breath or a persistent cough.
Beyond site-specific symptoms, stage IV cancer commonly causes bodywide effects: extreme fatigue that doesn’t improve with rest, unintentional weight loss, and loss of appetite. Some people experience a condition called cachexia, a severe wasting of muscle and fat tissue driven by the cancer itself, not simply by eating less.
How Stage IV Is Diagnosed
Doctors use a system called TNM staging, which evaluates three things: the size of the original tumor (T), whether nearby lymph nodes are involved (N), and whether the cancer has metastasized to distant sites (M). Any cancer classified as M1, meaning distant metastasis is confirmed, is stage IV regardless of the tumor’s size or lymph node status. Imaging scans like CT, PET, and MRI are the primary tools for detecting distant spread, sometimes supported by biopsies of suspicious areas.
Treatment Goals at Stage IV
For most stage IV cancers, the primary goal of treatment shifts from cure to extending life and managing symptoms. This doesn’t mean treatment is less aggressive or less important. It means the strategy changes. Rather than trying to eliminate every cancer cell, treatment aims to control growth, shrink tumors, relieve symptoms, and preserve quality of life for as long as possible.
Doctors increasingly distinguish between three categories of treatment intent. Curative treatment aims for complete remission. Life-extending treatment aims to meaningfully prolong survival without expecting a cure. Palliative treatment focuses specifically on relieving symptoms like pain, nausea, or breathing difficulty. Many stage IV patients receive a combination of life-extending and palliative treatments at the same time.
When Cure Is Still Possible
There’s an important exception. Some stage IV patients have what’s called oligometastatic disease, meaning the cancer has spread to only a small number of spots. This is considered an intermediate state between localized and widely spread cancer. When metastases are limited, aggressive local treatments (like surgery or targeted radiation to the metastatic sites) can sometimes be curative. This concept, first proposed in 1995, has become increasingly recognized and has changed outcomes for a subset of stage IV patients.
How Modern Treatments Have Changed Outcomes
Stage IV cancer survival has improved substantially over the past decade, largely due to immunotherapy and targeted therapies. In advanced lung cancer, for example, immunotherapy drugs that help the immune system recognize and attack cancer cells have shown striking results. In one major trial, patients whose tumors had high levels of a specific protein (PD-L1) survived a median of 20 months on immunotherapy compared to 12.2 months on traditional chemotherapy. Another trial combining immunotherapy with chemotherapy improved median survival from 13.9 months to 18.5 months.
Real-world data backs this up. Studies outside of clinical trials have shown that patients with advanced lung cancer who received only chemotherapy had an 80% higher risk of death compared to those who received immunotherapy. These improvements aren’t limited to lung cancer. Immunotherapy and targeted treatments have transformed outcomes in melanoma, kidney cancer, bladder cancer, and several other types.
Survival Rates Vary Widely
Five-year survival rates for stage IV cancer vary enormously depending on the cancer type. Based on data from the National Cancer Institute’s SEER program covering 2015 to 2021, distant-stage breast cancer has a five-year relative survival rate around 31 to 37%, while distant-stage prostate cancer is considerably higher. Distant-stage lung cancer, historically one of the poorest, has seen meaningful improvement and now sits in the range of roughly 9 to 12% overall, though this figure is rising as immunotherapy data matures.
These numbers represent averages across all patients, including those diagnosed years ago with older treatments. Individual prognosis depends on many factors: the specific cancer type, its genetic profile, how many sites are involved, your overall health, and which treatments are available. A stage IV diagnosis today carries significantly different odds than the same diagnosis even five years ago.
The Role of Palliative Care
Palliative care is often misunderstood as end-of-life care, but it’s actually most effective when started early alongside active treatment. In a landmark study of 151 patients with advanced lung cancer, those who received early palliative care alongside standard treatment had better quality of life, less depression, and lived longer: a median of 11.6 months compared to 8.9 months for those receiving standard care alone. That’s a nearly three-month survival advantage from supportive care, not from a new drug.
Early palliative care provides ongoing management of pain, nausea, fatigue, and other symptoms. It also offers psychological support and helps patients and families navigate decisions about treatment goals. Studies have consistently shown it reduces end-of-life care costs as well. Some cancer centers have renamed their palliative care departments to “supportive care” to reduce stigma, and one center saw referrals increase by 41% after the name change alone.